1.Multiple Thymoma with Myasthenia Gravis.
The Korean Journal of Thoracic and Cardiovascular Surgery 2017;50(1):68-70
The actual incidence of multiple thymoma is unknown and rarely reported because it remains controversial whether the cases represent a disease of multicentric origin or a disease resulting from intrathymic metastasis. In this case, a patient underwent total thymectomy for multiple thymoma with myasthenia gravis via bilateral video-assisted thoracic surgery. A well-encapsulated multinodular cystic mass, measuring 57 mm×50 mm×22 mm in the right lobe of the thymus, and a well-encapsulated mass, measuring 32 mm×15 mm×14 mm in the left lobe, were found. Both tumors were type B2 thymoma. Few cases of multiple thymoma with myasthenia gravis have ever been reported in the literature. We report a case of synchronous multiple thymoma associated with myasthenia gravis.
Humans
;
Incidence
;
Myasthenia Gravis*
;
Neoplasm Metastasis
;
Thoracic Surgery, Video-Assisted
;
Thymectomy
;
Thymoma*
;
Thymus Gland
2.Effectiveness of thymectomy in non-thymomatous myasthenia gravis: a systematic review.
Yan LUO ; Deng-ji PAN ; Fei-fei CHEN ; Ming-hui ZHU ; Jing WANG ; Min ZHANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2014;34(6):942-949
There is continuous debate regarding the effectiveness of thymectomy in the treatment of non-thymomatous myasthenia gravis (MG). This systematic review was undertaken to determine whether thymectomy was effective in non-thymomatous MG. We retrieved articles published between January 1980 and September 2013. Sixteen cohort studies were included. Given the considerable heterogeneity, we used a descriptive method instead of statistical synthesis. The median relative rates (RRs) and their interquartile ranges were used to estimate the magnitude of benefit. Compared to conservatively treated MG patients, thymectomized patients had higher survival, clinical remission, pharmacologic remission and improvement rates, and RRs were 1.07 (1.01-1.17), 1.83 (0.82-2.99), 1.55 (1.22-1.95) and 1 (1.00-1.09), respectively. Subgroup analyses showed that patients with moderate to severe generalized MG benefited more from thymectomy, with RRs of survival and pharmacologic remission increasing to 1.35 (1.24-1.49) and 2.68 (1.73-4.17), respectively. These results suggested that thymectomy might be an effective procedure in non-thymomatous MG patients. The patients with moderate to severe generalized MG might benefit more. Taking into account the poor methodological quality of present studies, more well-designed prospective randomized controlled trials (RCTs) are still required to reach unequivocal conclusion.
Disease-Free Survival
;
Humans
;
Myasthenia Gravis
;
mortality
;
surgery
;
Survival Rate
;
Thymectomy
3.Anesthetic considerations for a patient with myasthenia gravis undergoing deep sedation in an outpatient oral surgery setting
Shamit S PRABHU ; Saad A KHAN ; Alexander L DOUDNIKOFF ; Uday N REEBYE
Journal of Dental Anesthesia and Pain Medicine 2019;19(1):67-72
Myasthenia gravis (MG) is a neuromuscular autoimmune disorder which clinically presents as muscular weakness and fatigue due to autoantibody formation against acetylcholine receptors (AChR), leading to their subsequent destruction. Due to the neuromuscular implications of MG, certain considerations must be taken into account when providing anesthesia to MG patients. In the following case report, we have outlined procedural considerations for the anesthetic management of a patient with MG undergoing deep sedation for an elective oral surgery in an outpatient setting, as well as a discussion of relevant literature.
Anesthesia
;
Deep Sedation
;
Fatigue
;
Humans
;
Muscle Weakness
;
Myasthenia Gravis
;
Outpatients
;
Receptors, Cholinergic
;
Surgery, Oral
4.Appearance of Systemic Lupus Erythematosus in Patients with Myasthenia Gravis following Thymectomy : Two Case Reports.
Mi Jeong PARK ; Yun A KIM ; Shin Seok LEE ; Byeong Chae KIM ; Myeong Kyu KIM ; Ki Hyun CHO
Journal of Korean Medical Science 2004;19(1):134-136
We report two cases of systemic lupus erythematosus (SLE) in myasthenia gravis (MG) patients who had undergone thymectomy. SLE developed in the patients 3 months or 13 yr after thymectomy, and polyarthritis was the main clinical manifestation of SLE. Both patients fulfilled at least four of the revised criteria for the classification of SLE. In this report, we describe two postthymectomy lupus patients and perform a comparative review of previous cases.
Adult
;
Female
;
Human
;
Lupus Erythematosus, Systemic/*diagnosis/etiology
;
Myasthenia Gravis/*diagnosis/therapy
;
Thymus Gland/*surgery
;
Time Factors
5.Myasthenia gravis in pediatric and elderly patients.
Wei LIU ; Guojin LIU ; Zhimin FAN ; Xueliang GAI
Chinese Medical Journal 2003;116(10):1578-1581
OBJECTIVETo determine whether the clinical and pathologic characteristics and prognoses of myasthenia gravis (MG) patients below 15 years differ from those patients over 50 years after thymectomy.
METHODSWe reviewed the registry material of 30 pediatric and 32 elderly MG patients after thymectomy, including their age, sex, clinical classification, pathological types, and prognoses. The Chi-square test or Wilcoxon's rank-sum test was used to determine the statistical differences between the children and elderly groups.
RESULTSNo significant difference was seen in sex distribution between the two groups. (Chi-square test, P=0.625), but there were differences in clinical classification: more type I was observed in the pediatric group than in the elderly group, but more type II or III was seen in the elderly group (Wilcoxon's rank-sum test, P<0.001). As to pathological types, the pediatric group was also significantly different from the elderly group (Chi-square test, P<0.01). All of the patients (100%) in the pediatric group had thymus hyperplasia, but in the elderly group more than half (56.26%) were found to have thymoma (benign or malignant). The prognoses after thymectomy were better in the pediatric group than in the elderly group (Wilcoxon's rank-sum test, P<0.001).
CONCLUSIONSBecause the prognoses are generally better than those of the elderly patients, we should be careful when operating on pediatric patients of ocular type. The elderly patients tend to receive more aggressive treatment because of more severe generalized types often associated with thymoma and poor prognoses. Both pediatric and elderly patients are seldom associated with other autoimmune disease.
Adolescent ; Aged ; Child ; Child, Preschool ; Female ; Humans ; Male ; Middle Aged ; Myasthenia Gravis ; mortality ; pathology ; surgery ; Prognosis ; Thymectomy
6.Application and curative effect of plasma exchange in myasthenia gravis patients with thymectomy.
Ya-mei SHEN ; Wei GONG ; Jian-xin LIU
Journal of Central South University(Medical Sciences) 2007;32(6):1089-1092
OBJECTIVE:
To explore the application of plasma exchange in myasthenia gravis (MG) patients with thymectomy, and to evaluate its curative effects.
METHODS:
The clinical data of 50 patients with thymectomy were analyzed retrospectively, and the patients were divided into Group A (23 cases, undergoing thymectomy and plasma exchange) and Group B (27 cases, undergoing thymectomy). The difference of serum concentration of AChRab was examined by ELISA, and the time of auxiliary breath, crisis of myasthenia and clinical evaluation in the 2 groups were compared.
RESULTS:
Serum concentration of AChRab in Group A descended obviously after the plasma exchange. One day and one week after the operation, the AChRab concentration in Group A was obviously lower than that in Group B, but there was no difference one month after the operation. One week after the operation, the time of auxiliary breath,crisis of myasthenia and clinical evaluation in Group A were less than those in Group B.
CONCLUSION
Plasma exchange together with thymectomy can improve the temporary curative effects in patients with MG. It is safe and effective for MG.
Adolescent
;
Adult
;
Female
;
Humans
;
Male
;
Middle Aged
;
Myasthenia Gravis
;
surgery
;
Plasma Exchange
;
Retrospective Studies
;
Thymectomy
;
methods
;
Treatment Outcome
;
Young Adult
7.Transsternal Maximal Thymectomy is Effective for Extirpation of Cervical Ectopic Thymic Tissue in the Treatment of Myasthenia Gravis.
Chang Young LEE ; Jin Gu LEE ; Woo Ik YANG ; Suk Jin HAAM ; Kyung Young CHUNG ; In Kyu PARK
Yonsei Medical Journal 2008;49(6):987-992
PURPOSE: Extensive extirpation of cervico-mediastinal adipose tissue increases the chance of removing ectopic thymic tissues, thus potentially improving the prognosis of myasthenia gravis after thymectomy. We sought to increase efficacy and safety of transsternal maximal thymectomy (TSMT). MATERIALS AND METHODS: Twenty four patients who underwent TSMT from July 2006 to June 2007 were retrospectively reviewed and compared with 73 patients who underwent transsternal extended thymectomy (TSET) from January 2004 to May 2006. Ectopic thymic tissue in additionally excised cervicomediastinal fat tissue was examined histologically. RESULTS: In TSMT group, operation time, amount of cumulative drainage and duration of drainage were significantly higher than TSET group. However, the difference in hemoglobin count, amount of transfusion, duration of intensive care, postoperative hospital stay, and complication rates were not statistically different. There was no operative mortality in either group. Ectopic thymic tissue was found in 50% of patients. All patients had ectopic thymic tissues in the cervical area. Two patients had additional ectopic tissue in the aortopulmonary window, and 1 patient had ectopic tissue at posterior of the left bracheocephalic vein and lateral of the right phrenic nerve. CONCLUSION: TSMT is more effective in the extirpation of ectopic thymic tissues than TSET without significant impairment of safety, especially in the cervical area.
Adipose Tissue/pathology/surgery
;
Adult
;
Choristoma/pathology/surgery
;
Female
;
Humans
;
Male
;
Middle Aged
;
Myasthenia Gravis/*surgery
;
Neck
;
Retrospective Studies
;
Thymectomy/*methods
;
Thymus Gland
;
Young Adult
8.Localized thymic Langerhans cell histiocytosis with myasthenia gravis.
Chinese Journal of Pathology 2005;34(7):401-401
Adult
;
Antigens, CD1
;
metabolism
;
Female
;
Histiocytosis, Langerhans-Cell
;
complications
;
metabolism
;
pathology
;
surgery
;
Humans
;
Mediastinoscopy
;
Myasthenia Gravis
;
complications
;
metabolism
;
pathology
;
surgery
;
S100 Proteins
;
metabolism
;
Thymus Gland
;
metabolism
;
pathology
;
surgery
9.Perioperative and long-term outcome of thymectomy for myasthenia gravis: comparison of surgical approaches and prognostic analysis.
Cheng-wu LIU ; Meng LUO ; Jian-dong MEI ; Yun-ke ZHU ; Qiang PU ; Lin MA ; Guo-wei CHE ; Yi-dan LIN ; Zhu WU ; Yun WANG ; Ying-li KOU ; Lun-xu LIU
Chinese Medical Journal 2013;126(1):34-40
BACKGROUNDThymectomy is an established treatment for myasthenia gravis (MG), and video-assisted thoracoscopic surgery (VATS) thymectomy has become an acceptable surgical procedure. This study aimed to compare the results of VATS thymectomy and open thymectomy and to identify the prognostic factors after thymectomy.
METHODSThe clinical data of 187 consecutive thymectomies performed between July 2000 and December 2009 were retrospectively reviewed; 75 open thymectomies and 112 VATS thymectomies. Clinical efficacy and variables influencing outcome were assessed by Kaplan-Meier survival curves and Cox proportional hazards regression analysis.
RESULTSThe operative blood loss in the VATS group was significantly less than that in the open group ((62.14 ± 55.43) ml vs. (137.87 ± 165.25) ml, P < 0.05). The postoperative crisis rate increased with the severity of preoperative MG and the prescription dose of anticholinesterase. Complete follow-up information of patients more than 12 months after the thymectomy was obtained on 151 cases, 89 cases from the VATS group and 62 cases from the open group, with a mean follow-up period of 59.3 months, range from 12 to 117 months. Complete stable remission (CSR) was the end point for evaluation of the treatment results. The overall five-year CSR rate was 57.5%. Two good prognostic factors were identified; preoperative prescription of anticholinesterase alone (P = 0.035) and non-thymomatous MG (P = 0.003). The five-year CSR rate of the ocular type of MG reached a high level of 67.4%.
CONCLUSIONSThymectomy can achieve good long-term CSR in MG, and VATS is an ideal alternative method. High-dose prescription of anticholinesterase and the advanced stage by Myasthenia Gravis Foundation of America (MGFA) classification have higher risks of postoperative crisis. Preoperative prescription of anticholinesterase alone and non-thymomatous MG are good prognostic factors. Thymectomy should also be considered for the ocular type of MG.
Adolescent ; Adult ; Aged ; Child ; Female ; Humans ; Male ; Middle Aged ; Myasthenia Gravis ; surgery ; Proportional Hazards Models ; Thoracic Surgery, Video-Assisted ; methods ; Thymectomy ; adverse effects ; methods ; Time Factors ; Treatment Outcome
10.The comparative analysis of video-assisted thoracoscopic versus transsternal thymectomy for myasthenia gravis.
Yun-feng ZHANG ; Shan MA ; Jian-ye LI ; Lei YU ; Hai-feng ZHANG
Chinese Journal of Surgery 2009;47(5):366-368
OBJECTIVETo investigate different characteristics of the video-assisted thoracoscopic (VATS) versus transsternal thymectomy for myasthenia gravis (MG).
METHODSThe clinical data of 106 patients who underwent VATS thymectomy for MG between February 2002 and May 2007, and 108 patients who underwent transsternal thymectomy between March 1998 and August 2003 were analyzed retrospectively. In VATS group, there were 64 male and 42 female patients, and the mean age was 38-years-old. In the transsternal group, 68 patients were male and 40 were female, and the mean age was 36-years-old. Analysis of conditions related to the surgical procedure between two groups was made, such as length of surgery, operative bleeding, postoperative drainage, hospital stay, hospitalization expenses and complications. The mean time of follow-up was 38.5 months (ranging from 10 to 67 months). All patients were classified according to the MGFA clinical classification.
RESULTSIntraoperative bleeding in VATS group was (34 +/- 5) ml, significantly less than (150 +/- 23) ml in the transsternal group. Postoperative drainage in VATS group was (42 +/- 18) ml, significantly less than (168 +/- 31) ml in the transsternal group. Complications and hospital stay in VATS group were also significantly lower than those in the transsternal group. There was no significantly different in the long-term outcome between two groups.
CONCLUSIONAlthough both thoracoscopic and transsternal approaches to thymectomy in patients with MG are effective after the long-term follow-up, VATS thymectomy has its specific advantages of minimal invasion, less complications, and rapid recovery.
Adolescent ; Adult ; Aged ; Child ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Myasthenia Gravis ; surgery ; Retrospective Studies ; Thoracic Surgery, Video-Assisted ; Thymectomy ; methods ; Treatment Outcome ; Young Adult